SYShinichi Yamauchi

Shinichi Yamauchi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shinichi Yamauchi has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparison of short-term outcomes and defecatory function following robotic and conventional laparoscopic surgery for stapled-ileal pouch-anal anastomosis: a retrospective cohort study

    by Marie Hanaoka, Yusuke Kinugasa, Kenta Yao, Ayumi Takaoka, Megumi Sasaki, Shinichi M.D Yamauchi, Masanori Tokunaga

    Background: This study assessed the potential advantages of robotic-assisted Stapled ileal pouch-anal anastomosis (Ro Stapled-IPAA) in ulcerative colitis (UC) compared to conventional laparoscopic surgery (Lap), with a focus on short-term outcomes and postoperative defecatory function, an aspect not previously explored. Materials and methods: Out of a total of 132 patients who underwent proctocolectomy or residual rectal resection, consecutive patients undergoing minimally invasive Stapled-IPAA for UC at our hospital from May 2014 to May 2024 were included. The Ro approach was chosen for individuals with severe colitis extending into the anal canal, deeper rectal cancers (beyond T1), and cases requiring residual rectal resection, taking advantage of its benefits. Perioperative outcomes, including anastomosis height, operative time, intraoperative blood loss, complication rate, postoperative hospital stay, and defecatory function using Wexner scores and anorectal manometry before proctocolectomy and 6 months after stoma closure, were compared between the Ro and Lap groups. Results: Thirty-three patients (Lap, n=21; Ro, n=12) were included. The Ro group demonstrated a significantly lower anastomosis height (0.5 vs. 3.0 cm, PP=0.032), shorter postoperative hospital stay (8 vs. 10.5 days), and no cases of anastomotic leakage (0 vs. 14.3%), as compared to the Lap group. Pouch failure occurred in 14% of Lap group; none were observed in the Ro group. Wexner scores favored the Ro group at 12 months after stoma closure (0 vs. 8 points), and there was better maximum voluntary squeeze pressure (302 mmHg vs. 175 mmHg, P=0.03), indicating preserved contraction of the external sphincter muscle despite the lower anastomosis. Conclusion: Ro Stapled-IPAA for patients with UC led to better short-term outcomes and preservation of defecatory function with lower anastomosis than Lap, suggesting the clinical advantages of the robotic approach in this field.


  • Open Access

    Preferences of patients with cancer for psychological counseling: a cross-sectional study using full-profile conjoint analysis in Japan

    by Kanako Ichikura, Sayuri Shimizu, Noriko Oshima, Yosuke Ariizumi, Toshihide Fujie, Shin-Ichi Yamauchi, Toshiaki Ishikawa, Yasuaki Nakajima, Yuko Fukase, Norio Murayama, et al.

    Background: Psychological counseling is an effective nonpharmacological intervention for patients with cancer experiencing psychological distress. This study used a conjoint analysis approach to assess the preferences of patients with cancer for psychological counseling. Methods: We conducted a single-center, cross-sectional study using a self-report questionnaire. Data were collected from outpatients and inpatients in the departments of respiratory medicine, gastrointestinal surgery, female pelvic surgery, and head and neck surgery at a university hospital between March 2018 and March 2020. The questionnaire was developed using semistructured interviews with 10 clinical psychologists. It included 48 scenarios to determine patients' preferences for counseling based on a combination of the type, length, cost, and frequency of counseling. We performed a conjoint analysis, calculating the relative importance and part-worth utility value of each factor. Results: The results of the conjoint analysis showed that patients with cancer considered counseling type as the most important factor (relative importance: 37.5%), followed by frequency (23.4%), cost (19.6%), and length (19.5%). Patients with cancer valued life reviews more highly than problem-solving, emotional control, and emotional expression. However, women and younger patients valued counseling for emotional control the most, and patients with advanced cancer valued counseling for problem-solving the most. Conclusions: The results suggest that patients with cancer consider the type and content of counseling to be the most important factors in their decision process, although these preferences vary with individual characteristics. This is the first study to clarify the preferences of patients with cancer for psychological counseling using a conjoint analysis, and it proposes a new economic approach in the field of psycho-oncology.


  • Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre study

    by Tomoki Yamano, Shinichi Yamauchi, Kei Kimura, Akihito Babaya, Michiko Hamanaka, Masayoshi Kobayashi, Miki Fukumoto, Kiyoshi Tsukamoto, Masafumi Noda, Naohiro Tomita, et al.


    • 1 February 2016
      • Vol. 43  (2) , 156-9

    [Adjuvant Chemotherapy for Colorectal Cancer].

    by Shinichi Yamauchi, Hiroyuki Uetake, Toshiaki Ishikawa, Megumi Ishiguro, Masamichi Yasuno

    The purpose of adjuvant chemotherapy for patients with colorectal cancer treated with curative surgery is to prevent from metachronous recurrences and to improve their prognosis. Because surgical outcomes in Japan are relatively better compared to those in western countries, optimal and personalized treatment based on evidence introduced not only by other countries but by Japan should be chosen. We now focus on a research of identification of biomarker which predict high risk of recurrence in Stage II colorectal cancer.

  • Use of genetic variants in c-MET to predict clinical outcome in localized gastric cancer (GC) patients (pts) treated with surgery.

    by Yu Sunakawa, Takeru Wakatsuki, Wu Zhang, Dongyun Yang, Mizutomo Azuma, Yan Ning, Sebastian Stintzing, Stefan Stremitzer, Shinichi Yamauchi, Ana Sebio, et al.

    50 Background: Dysregulation of the c-MET signaling pathway occurs in a wide range of human cancers including GC. Such derangements result from various molecular mechanisms, including mutations, amplification and overexpression of c-MET. Overexpression and amplification of c-MET have been correlated with poor clinical outcomes in pts with GC. However, the association between c-MET polymorphisms and prognosis in GC is not well defined. We examined the prognostic impact of c-MET polymorphisms on clinical outcomes in pts with localized GC treated with surgery. Methods: One-hundred and sixty-one Japanese pts were included, with localized GC (stage Ib-IV) treated with surgery alone (n=58), or surgery plus adjuvant therapy (n=103) between 2002 and 2010. Median follow up was 4 years. Genomic DNA was extracted from the pts’ blood or tissue. Six functionally significant c-MET SNPs (rs1621, rs40239, rs41736, rs41739, rs184953, rs10234854) were analyzed by PCR-based direct sequencing. All candidate SNPs were analyzed for association with disease free survival (DFS) and overall survival (OS) by uni- and multivariate analyses, adjusting for age, sex, stage and type of adjuvant therapy. Results: The MET rs40239 variant was associated with favorable clinical outcomes. Univariate analysis showed pts with any G (AG/GG) allele had significantly longer DFS and OS compared to those with the AA genotype (HR: 0.43; 95% CI: 0.25-0.74; P=0.001, HR: 0.47; 95% CI: 0.27-0.81; P=0.006, log-rank test, respectively); this remained significant upon multivariate analysis (HR: 0.48; 95% CI: 0.27-0.83; P=0.009, HR: 0.50; 95% CI: 0.28-0.88; P=0.017, respectively). In the subgroup analysis by gender, men, but not women, with the AG/GG genotypes maintained a DFS and OS benefit. Conclusions: Our results show for the first time that the c-MET polymorphism, rs40239, may serve as a prognostic marker in pts with localized GC treated with surgery. There also appears to be a gender-related difference in the impact on clinical outcome by genetic variants of c-MET. Prospective validation of this study is warranted.

    • 1 November 2012
      • Vol. 39  (12) , 2077-9

    [A case of metastatic breast cancer with bilateral hydronephrosis effectively treated with capecitabine].

    by Shinichi Yamauchi, Tsuyoshi Nakagawa, Mai Kasahara, Hitoshi Sugimoto, Toshiyuki Ishiba, Nobuko Tamura, Makoto Nagahara, Takanobu Sato, Kenichi Sugihara

    A 54-year-old female was diagnosed with invasive ductal carcinoma (pT3N1M0, Stage IIIA, estrogen receptor positive [ER (+)], progesterone receptor positive [PgR (+)], human epidermal growth factor receptor type 2 [HER2] score 0) and was treated by preoperative chemotherapy with weekly paclitaxel followed by 5-fluorouracil(5-FU) plus epirubicin plus cyclophosphamide regimen(FEC). Partial mastectomy with axillary dissection was performed. The pathological examination disclosed that the tumor was scirrhous carcinoma, and a pathological partial response was achieved by chemotherapy. Multiple bone metastases were detected 18 months after the surgery during treatment with letrozole as adjuvant therapy. Retroperitoneal metastases with hydronephrosis and a lung metastasis were detected 28 months after the surgery, even though exemestane and zoledronate were administrated after detection of the bone metastases. Chemotherapy with capecitabine was started and she recovered from hydronephrosis 4 months after the start of treatment. After 32 months from the first treatment with capecitabine, the patient is presently alive without hydronephrosis due to continued chemotherapy.

    • 1 November 2012
      • Vol. 39  (12) , 2264-6

    [A case of advanced rectal cancer with lung and bone metastasis that was successfully treated with mFOLFOX6+bevacizumab].

    by Taiki Masuda, Hiroyuki Uetake, Shinichi Yamauchi, Satoshi Okazaki, Takatoshi Matsuyama, Megumi Ishiguro, Toshiaki Ishikawa, Hirotoshi Kobayashi, Satoru Iida, Tetsuro Higuchi, et al.

    A 48-year-old man with respiratory discomfort was diagnosed with rectal cancer with carcinomatous lymphangiosis, together with lung and sternum metastasis. As the patient's performance status(PS) was 2, mFOLFOX6+bevacizumab (Bmab)therapy with a 20% reduction in the dose was started. Three courses of this treatment resulted in improved respiratory function, and his PS dropped to 1. A chest computed tomography(CT) scan taken after four courses of this treatment indicated that pleural effusion had almost disappeared, and that the shadow on the lung had also reduced. However, after 20 courses of this treatment the disease had progressed. The regimen was changed to irinotecan (CPT-11)+Bmab administration. All of these chemotherapeutic treatments were administered on an outpatient basis. Sixteen months after the diagnosis of rectal cancer, the patient died. In recent years, combination chemotherapy for unresectable colorectal cancer has become recognized as a standard regimen, though adverse effects frequently occur. Thus, intensive chemotherapy is not always recommended for patients with poor PS. In this report, we presented a case of pulmonary metastases from rectal cancer, carcinomatous lymphangiosis, and sternum metastasis that was successfully treated with mFOLFOX6+Bmab.

    • 1 November 2012
      • Vol. 39  (12) , 2280-2

    [A case of sigmoid colon cancer, successfully treated by a multidisciplinary strategy for local recurrence and distant metastases].

    by Satoshi Okazaki, Hiroyuki Uetake, Taiki Masuda, Shinichi Yamauchi, Takatoshi Matsuyama, Megumi Ishiguro, Hirotoshi Kobayashi, Toshiaki Ishikawa, Satoru Iida, Tetsuro Higuchi, et al.

    We report a case of sigmoid colon cancer, successfully treated by a multidisciplinary strategy for local recurrence and distant metastases. This 60-year-old male patient underwent sigmoidectomy for sigmoid colon cancer. Three years after the operation, local recurrence with invasion to the left ureter was found, and we performed colectomy and left nephroureterectomy. One year after the resection, a second relapse lesion was discovered, which was considered unresectable, and was treated instead with radiation therapy(total 50 Gy). One year after the radiation therapy, five pulmonary metastases each of 12 mm in diameter were found in both lungs. He had renal dysfunction due to nephrectomy. Several regimens of chemotherapy [irinotecan (CPT-11), capecitabine+oxaliplatin (CapeOx) and CPT-11+panitumumab] were performed. He is still alive 7.5 years after the initial surgery and 4.5 years after the first recurrence.

    • 1 November 2011
      • Vol. 38  (12) , 2268-70

    [A case of colonic neuroendocrine carcinoma with severe liver dysfunction by multiple liver metastases successfully treated with hepatic arterial infusion].

    by Akifumi Kikuchi, Shinichi Yamauchi, Hiroaki Ono, Syunsuke Kato, Megumi Ishiguro, Toshiaki Ishikawa, Hirotoshi Kobayashi, Satoru Iida, Hiroyuki Uetake, Tetsuro Higuchi, et al.

    A 63-year-old male was diagnosed as ascending colon cancer with severe liver dysfunction caused by multiple liver metastases. Initially, hepatic arterial infusion (HAI) chemotherapy was started to reduce the size of metastatic tumors and to prevent a liver failure. After 7 courses of HAI chemotherapy, he recovered from liver dysfunction, and underwent right hemicolectomy. Pathological examination of the resected specimen revealed the tumor was neuroendocrine carcinoma. After surgery, a systemic infusion of mFOLFOX6/bevacizumab regimen was started. A partial response (PR) of metastatic lesions was observed. Irinotecan/cetuximab was administered as the second-line. He survived for 10 months after HAI. HAI for colonic neuroendocrine carcinoma with severe liver dysfunction by multiple liver metastases might be benefitial to prevent a liver failure.


    • 1 November 2011
      • Vol. 38  (12) , 2271-3

    [A long-term survival case of neuroendocrine tumor of the sigmoid colon with multiple liver metastases].

    by Shinichi Yamauchi, Hiroyuki Uetake, Akifumi Kikuchi, Hiroaki Ono, Takatoshi Matsuyama, Shunsuke Kato, Megumi Ishiguro, Toshiaki Ishikawa, Hirotoshi Kobayashi, Satoru Iida, et al.

    It has been reported that neuroendocrine tumor (NET) of the large intestine with distant metastasis is rare and carries poor prognosis. We report a case of colonic NET with hepatic metastases, who was successfully treated by combined therapy. A 71-year-old man with sigmoid colon tumor underwent sigmoidectomy and histopathological examination disclosed the tumor was NET grade 1. Multiple liver metastases and lymph node metastasis on the posterior surface of the pancreatic head were detected at the time of surgery. Trans-catheter arterial chemoembolization (TACE; doxorubicin and ethiodized oil and gelatine sponge particle) was performed. Partial response (PR) was observed after 2 times of administration. Radiation therapy was performed for the lymph node metastasis eight months after surgery and PR was observed. The patient was alive after 48 months and TACE was continued. Combined therapy including surgery, irradiation, and chemotherapy, although not yet standardized, is required against NET with hepatic metastases.